Xenetic Biosciences Stock (NASDAQ: XBIO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 13.05K |
Day Range | - - - |
52 Wk Range | 2.78 - 5.97 |
Market Cap | $6.12M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 0.38% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xenetic Biosciences (NASDAQ:XBIO) through any online brokerage.
Other companies in Xenetic Biosciences’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Coeptis Therapeutics (NASDAQ:COEP) and NuCana (NASDAQ:NCNA).
There is no analysis for Xenetic Biosciences to provide a consensus price target.
The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $3.97 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Xenetic Biosciences.
Xenetic Biosciences’s Q3 earnings are confirmed for Friday, November 8, 2024.
There is no upcoming split for Xenetic Biosciences.
Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.